NASDAQ:BDTX | Cash Flow Statement | Black Diamond Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$9.91M
2026-03-31-$9.04M-$10.23M$19.5M-$185,000.00
2025-12-31-$15.12M-$6.79M-$2.89M-$196,000.00
2025-09-30-$8.5M
2025-06-30-$10.56M
2025-03-31$56.54M$53.41M$8.55M$32,000.00
2024-12-31-$15.99M-$15.06M$0.00$27.77M$291,000.00
2024-09-30-$15.56M
2024-06-30-$19.91M
2024-03-31-$18.23M-$21.2M-$13.73M$4.13M
2023-12-31-$19.41M-$13.96M$0.00$12.25M-$46,000.00
2023-09-30-$23.01M
2023-06-30-$19.15M
2023-03-31-$20.88M-$20.03M$0.00$24.81M$51,000.00
2022-12-31-$21.08M-$21.94M$0.00$2.32M-$28,000.00
2022-09-30-$21.65M
2022-06-30-$22.93M
2022-03-31-$25.51M-$28.6M$7,000.00$16.73M$153,000.00
2021-12-31-$25.87M-$24.05M$333,000.00$43.24M$0.00
2021-09-30-$35.08M
2021-06-30-$34.35M
2021-03-31-$30.3M-$24.46M$40,000.00$3.47M$481,000.00
2020-12-31-$22.63M-$15.77M$109,000.00-$6.65M$830,000.00
2020-09-30-$17.91M
2020-06-30-$14.57M
2020-03-31-$12.15M-$11.32M$0.00$0.00$213.84M
2019-12-31-$9.88M-$7.49M$2,000.00-$2,000.00$83.5M
2019-09-30-$9.27M
2019-06-30-$12.29M
2019-03-31-$3.83M-$6.88M$10,000.00-$10,000.00$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$22.37M$29.61M-$44.91M-$146,000.00
2024-12-31-$69.68M-$62.3M$0.00$16.97M$25.55M
2023-12-31-$82.44M-$66.72M$33,000.00$16.35M$71.93M
2022-12-31-$91.17M-$85.08M$192,000.00$53.37M$177,000.00
2021-12-31-$125.6M-$100.15M$2.71M$130.61M$729,000.00
2020-12-31-$67.25M-$52.15M$142,000.00-$281.69M$214.94M
2019-12-31-$35.26M-$24.67M$21,000.00-$21,000.00$127.76M
2018-12-31-$8.93M-$8.45M$76,000.00-$76,000.00$52.31M